Context: Although several formulation strategies have been developed for the treatment of psoriasis, there is an unmet need for optimization of its therapy. Objective: The objective was to develop a nanogel composed of Acitretin (ACT) loaded nanostructured lipid carrier (ACT-NLC) and to evaluate its potential in imiquimod-induced psoriasis model to ameliorate symptoms of psoriasis. Materials and methods: The developed control (CNGs) nanogels, acitretin loaded nanogels (ActCNGs) were characterized by UV and FTIR. Results and discussion: The systems were found to be spherical in shape with a size range of 98±10, and 138±8 nm having zeta potential values of +28±3 and +27±3 mV for CNGs and ActCNGs respectively. The in vitro haemolysis assay revealed that all the nanogel systems are blood compatible. The systems exhibited higher swelling and release at acidic pH. The ex vivo skin permeation studies using porcine skin confirmed the higher deposition of the systems at epidermal and dermal layers, which was confirmed further by fluorescent imaging. The in vivo anti-psoriatic activity study using Perry's mouse tail model and skin safety studies confirmed the potential benefit of the system for topical delivery of acitretin in psoriasis.
Cite this article:
Dethliya Madhuri, Jain Neetesh Kumar. Formulation and Evaluation of Nanogel used for the Treatment of Psorasis. Research Journal of Pharmaceutical Dosage Forms and Technology.2023; 15(1):19-4. doi: 10.52711/0975-4377.2023.00004
Dethliya Madhuri, Jain Neetesh Kumar. Formulation and Evaluation of Nanogel used for the Treatment of Psorasis. Research Journal of Pharmaceutical Dosage Forms and Technology.2023; 15(1):19-4. doi: 10.52711/0975-4377.2023.00004 Available on: https://rjpdft.com/AbstractView.aspx?PID=2023-15-1-4
1. Tan, M. G.; Shear, N. H.; Walsh, S.; Alhusayen, R., Acitretin. J Cutan Med Surg 2017, 21 (1), 48-53.
2. Anjum, S.; Gupta, A.; Sharma, D.; Dalal, P.; Gupta, B., Skin compatibility and antimicrobial studies on biofunctionalized polypropylene fabric. Mater Sci Eng C Mater Biol Appl 2016, 69, 1043-50.
3. Hagen, M.; Baker, M., Skin penetration and tissue permeation after topical administration of diclofenac. Curr Med Res Opin 2017, 33 (9), 1623-1634.
4. Dozier, L.; Bartos, G.; Kerdel, F., "Apremilast and Psoriasis in the Real World: A Retrospective Case Series". J Am Acad Dermatol 2019, 56-68.
5. Avasatthi, V.; Pawar, H.; Dora, C. P.; Bansod, P.; Gill, M. S.; Suresh, S., A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol 2016, 21 (5), 554-62.
6. Richa; Roy Choudhury, A., Synthesis of a novel gellan-pullulan nanogel and its application in adsorption of cationic dye from aqueous medium. Carbohydr Polym 2020, 227, 115-291.
7. Adi, A. C.; Christanto, C.; Rachmawati, H.; Adlia, A., vitamin e-based folic acid nanoemulsion: formulation and physical evaluation for oral administration. pharm nanotechnol 2019, 7 (4), 304-313.
8. Sinha, P.; Srivastava, S.; Mishra, N.; Singh, D. K.; Luqman, S.; Chanda, D.; Yadav, N. P., Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology. Drug Dev Ind Pharm 2016, 42 (9), 1434-45.
9. Tchewonpi Sagu, S.; Huschek, G.; Bonick, J.; Homann, T.; Rawel, H. M., A New Approach of Extraction of alpha-Amylase/trypsin Inhibitors from Wheat (Triticum aestivum L.), Based on Optimization Using Plackett-Burman and Box-Behnken Designs. 2019, 24 (19).
10. Bonomo, L.; Abittan, B. J.; Hashim, P. W.; Karki, C.; Mason, M.; Lebwohl, M., Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry. J Drugs Dermatol 2019, 18 (8), 731-740.
11. Sonzogni, A. S.; Yealland, G.; Kar, M.; Wedepohl, S.; Gugliotta, L. M.; Gonzalez, V. D. G.; Hedtrich, S., effect of delivery platforms structure on the epidermal antigen transport for topical vaccination. 2018, 102-125.
12. Panonnummal, R.; Jayakumar, R.; Sabitha, M., Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream. Eur J Pharm Sci 2017, 96, 193-206.
13. Sanzhakov, M. A.; Ignatov, D. V.; Kostryukova, L. V.; Druzhilovskaya, O. S.; Medvedeva, N. V.; Prozorovskyi, V. N.; Ipatova, O. M., [The in vivo study of the medicinal composition property of doxorubicin as a part of colloidal nanoparticles with the address fragment]. Biomed Khim 2016, 62 (2), 150-3.
14. Divya, G.; Panonnummal, R.; Gupta, S.; Jayakumar, R.; Sabitha, M., Acitretin and aloe-emodin loaded chitin nanogel for the treatment of psoriasis. Eur J Pharm Biopharm 2016, 107, 97-109.
15. Porwal, P. K.; Upmanyu, N., Assessment by HPLC of the degradation behavior of acitretin under hydrolytic, oxidative, photolytic and thermal stress conditions. Acta Pharm Sin B 2014, 4 (6), 438-46.
16. Rote, A. R.; Kumbhoje, P. A.; Bhambar, R. S., UV-visible spectrophotometric simultaneous estimation of paracetamol and nabumetone by AUC method in combined tablet dosage form. Pharm Methods 2012, 3 (1), 40-3.
17. Mousaviasl, S.; Saleh, T.; Shojaosadati, S. A.; Boddohi, S., Synthesis and characterization of schizophyllan nanogels via inverse emulsion using biobased materials. Int J Biol Macromol 2018, 120 (Pt A), 468-474.